J.-L. Canon

1.0k citations
16 papers · 334 indexed · h-index 7
Topics
Cancer Treatment and Pharmacology (7 papers)Colorectal Cancer Treatments and Studies (6 papers)HER2/EGFR in Cancer Research (5 papers)

In The Last Decade

J.-L. Canon

15 papers receiving 333 citations

Peers

J.-L. Canon
Comparison fields: 5 of 47
  • Oncology 288
  • Surgery 122
  • Pulmonary and Respiratory Medicine 105
  • Molecular Biology 30
  • Hepatology 30
Replace Soetkin Vlassak with:
Soetkin Vlassak Germany
Javier Rodríguez Spain
Wanda Honeycutt United States
Makio Gamoh Japan
Suprith Badarinath United States
M. Karina Greece
Silvia Hanselmann Switzerland
C. Bosch Spain
Ramón Barceló Spain
William Leslie United States
J.-L. Canon relative to Soetkin Vlassak Germany Soetkin Vlassak's profile →
Citations per field
00.5×1.5×
Soetkin Vlassak · 1×
Citations per year

Countries citing papers authored by J.-L. Canon

Since Specialization
Citations

This map shows the geographic impact of J.-L. Canon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-L. Canon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-L. Canon more than expected).

Fields of papers citing papers by J.-L. Canon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-L. Canon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-L. Canon. The network helps show where J.-L. Canon may publish in the future.

Co-authorship network of co-authors of J.-L. Canon

This figure shows the co-authorship network connecting the top 25 collaborators of J.-L. Canon. A scholar is included among the top collaborators of J.-L. Canon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-L. Canon. J.-L. Canon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 2
2 8
3 3
4 3
5 39
6 19
7 2
8 128
9 0
10 106
11
Sequential administration of epirubicin and paclitaxel for advanced breast cancer. A phase I randomised trial.
4
12 9
13 1
14 6
15
Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
3
16 1

About J.-L. Canon

J.-L. Canon is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 16 papers that have together received 334 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Oncology (288 citations), Hepatology (30 citations) and Pulmonary and Respiratory Medicine (105 citations). J.-L. Canon has collaborated with scholars based in Belgium, United States and Philippines. Frequent co-authors include Yves Humblet, Marc Peeters, Silvana Spadafora, Werner Scheithauer, Joan Maurel, Emilio Bajetta, Armando Santoro, Bart Neyns, Dusan Kotasek and Eric Van Cutsem. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026